The U.S. FDA postponed on enforcing the DSCSA (drug supply chain security act) by a year. They have postponed the deadline from November of 2017 to November of 2018. This coincides with Europe’s deadline, which is to be February of 2019. It was delayed due to the minimal progress is shown with the new DSCSA technology; most companies were not able to produce a valid and efficient track and trace method in time. However, it is not a good idea to delay the serialization as whatever ideas that could work should be placed on the market immediately.